☰

Carrie A. Franzen, Ph.D. - Publications

Affiliations: 
2006 University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612, United States 
Area:
Molecular Biology, Oncology, Cell Biology
Tree Info Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Wu W, Wang W, Franzen CA, Guo H, Lee J, Li Y, Sukhanova M, Sheng D, Venkataraman G, Ming M, Lu P, Gao A, Xia C, Li J, Zhang LL, et al. Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2. Blood Advances. 5: 185-197. PMID 33570628 DOI: 10.1182/bloodadvances.2020001665  0.5
2017 Blackwell RH, Franzen CA, Gupta GN. Exosomes: an evolving source of urinary biomarkers and an up-and-coming therapeutic delivery vehicle Translational Cancer Research. 6. DOI: 10.21037/11985  0.433
2016 Greco KA, Franzen CA, Foreman KE, Flanigan RC, Kuo PC, Gupta GN. PLK-1 Silencing in Bladder Cancer by siRNA Delivered with Exosomes. Urology. PMID 26876462 DOI: 10.1016/J.Urology.2016.01.028  0.484
2016 Blackwell RH, Franzen C, Zilliox M, Foreman KE, Kuo PC, Flanigan RC, Gupta GN. MP83-01 URINARY SHED BLADDER CANCER EXOSOMES HAVE DISTINCT MRNA PROFILES AND HAVE POTENTIAL AS URINARY BIOMARKERS Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2183  0.381
2015 Franzen CA, Blackwell RH, Foreman KE, Kuo PC, Gupta GN. Urinary Exosomes: The Potential for Biomarker Utility, Intercellular Signaling and Therapeutics in Urological Malignancy. The Journal of Urology. PMID 26714199 DOI: 10.1016/J.Juro.2015.08.115  0.466
2015 Franzen C, Greco K, Blackwell R, Foreman K, Gupta G. Mp49-08 Urothelial Cells Undergo Epithelial To Mesenchymal Transition After Exposure To Muscle Invasive Bladder Cancer Exosomes The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.512  0.433
2014 Weber CE, Kothari AN, Wai PY, Li NY, Driver J, Zapf MA, Franzen CA, Gupta GN, Osipo C, Zlobin A, Syn WK, Zhang J, Kuo PC, Mi Z. Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer. Oncogene. PMID 25531323 DOI: 10.1038/Onc.2014.410  0.456
2014 Franzen CA, Simms PE, Van Huis AF, Foreman KE, Kuo PC, Gupta GN. Characterization of uptake and internalization of exosomes by bladder cancer cells. Biomed Research International. 2014: 619829. PMID 24575409 DOI: 10.1155/2014/619829  0.547
2014 Mirzoeva S, Franzen CA, Pelling JC. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism. Molecular Carcinogenesis. 53: 598-609. PMID 23359392 DOI: 10.1002/Mc.22005  0.535
2014 Van Huis A, Franzen C, Foreman K, Gupta G. MP39-10 EXOSOME-MEDIATED REGULATION OF PTEN EXPRESSION IN BLADDER CANCER Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1325  0.511
2014 Greco KA, Franzen CA, Kuo PC, Foreman KE, Flanigan RC, Gupta GN. MP34-16 PLK1 SILENCING IN BLADDER CANCER BY SIRNA DELIVERED WITH EXOSOMES Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1029  0.449
2014 Driver J, Mi Z, Callaci J, Mascarenhas J, Franzen C, Gupta G, Wai P, Zhang J, Kuo P. Alcohol Inhibits Osteopontin Induced Expression of TGF-β1 in Human Mesenchymal Stem Cells: Implications for Fracture Healing in Intoxicated Patients Journal of Surgical Research. 186: 661-662. DOI: 10.1016/J.Jss.2013.11.715  0.353
2014 Driver J, Mi Z, Callaci JJ, Mascarenhas JB, Franzen CA, Gupta GN, Wai PY, Zhang J, Kuo PC. AAS Medical Student Quick Shot SessionAlcohol Inhibits Osteopontin Induced Expression of TGF-β1 in Human Mesenchymal Stem Cells: Implications for Fracture Healing in Intoxicated Patients Journal of Surgical Research. 186. DOI: 10.1016/J.Jss.2013.11.360  0.345
2012 Franzen CA, Todorović V, Desai BV, Mirzoeva S, Yang XJ, Green KJ, Pelling JC. The desmosomal armadillo protein plakoglobin regulates prostate cancer cell adhesion and motility through vitronectin-dependent Src signaling. Plos One. 7: e42132. PMID 22860065 DOI: 10.1371/Journal.Pone.0042132  0.684
2012 Franzen CA, Pelling JC, Bergan RC. Abstract 615: Apigenin regulates prostate cancer matrix composition and cell attachment through an integrin alpha 1 dependent pathway Cancer Research. 72: 615-615. DOI: 10.1158/1538-7445.Am2012-615  0.654
2012 Mirzoeva S, Franzen CA, Pelling JC. Abstract 5229: Apigenin inhibits TGF-beta-induced VEGF expression in human prostate carcinoma cells via Smad2/3 and Src/FAK/Akt signaling pathways Cancer Research. 72: 5229-5229. DOI: 10.1158/1538-7445.Am2012-5229  0.533
2009 Franzen CA, Amargo E, Todorovi? V, Desai BV, Huda S, Mirzoeva S, Chiu K, Grzybowski BA, Chew TL, Green KJ, Pelling JC. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prevention Research (Philadelphia, Pa.). 2: 830-41. PMID 19737984 DOI: 10.1158/1940-6207.Capr-09-0066  0.709
2008 Mirzoeva S, Kim ND, Chiu K, Franzen CA, Bergan RC, Pelling JC. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells. Molecular Carcinogenesis. 47: 686-700. PMID 18240292 DOI: 10.1002/Mc.20421  0.577
Show low-probability matches.